Nokia inks Samsung deal; Ericsson set for 5G licensing push; ERS Genomics willing to litigate CRISPR patents; AI data mining subject of new lawsuits; trade secrets moving to centre stage; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.

The Long Read

Your practical guide to obtaining patent protection for software. Read more here

MONDAY 23 January

Nokia inked a new cross-licence patent agreement with Samsung covering fundamental inventions in 5G and other technologies. Read more here

Ericsson set for 5G licensing push in wake of Apple settlement. Read more here

A data dive on how top US patent judges fare on appeal. Read more here

TUESDAY 24 January

Michael Arciero, VP for intellectual property and corporate development at ERS Genomics, revealed the company is willing to litigate its CRISPR patents. Read more here

Non-US companies earned 56% of US patent grants in 2022 as IBM loses top spot. Read more here

WEDNESDAY 25 January

$166.3 million infringement verdict hits AT&T over Nokia base stations. Read more here

New head of Mexican IP office begins work amid IP community concerns. Read more here

THURSDAY 26 January

Patents set to lose out as trade secrets take centre stage. Read more here

IPBC Europe 2023 is heading to Paris with a stellar speaker line-up. Read more here

Bristol-Myers Squibb seeks further immuno-oncology patent revenues with AstraZeneca suit. Read more here

FRIDAY 27 January

The future of AI data mining will be shaped by wave of new IP lawsuits. Read more here

Nokia’s Q4 IP revenues boosted by early Microsoft licence payments. Read more here

Apple victory overturning $308.5M verdict is a torpedo for ‘submarine patents’. Read more here

SATURDAY 28 January

Opinion: The FTC’s war against US technology competition with China. Read more here